These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9528635)

  • 21. Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis.
    Umubyeyi AN; Martin A; Zissis G; Struelens M; Karita E; Portaels F
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):808-11. PubMed ID: 16848345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemo-antibiotico-therapy today. I].
    Cairella M; Marasa G
    Clin Ter; 1974 Jun; 69(6):561-84. PubMed ID: 4845638
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current viewpoints on resistance of clinically important bacteria].
    Dimmling T
    Med Welt; 1973 Mar; 24(13):477-81. PubMed ID: 4746857
    [No Abstract]   [Full Text] [Related]  

  • 24. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
    Iavors'ka HV; Puhachevs'ka LP
    Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
    Dinçer I; Ergin A; Kocagöz T
    Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of common bacterial species--1969.
    Dalton HP; Escobar MR; Allison MJ
    Va Med Mon (1918); 1970 Dec; 97(12):770 passim. PubMed ID: 5528055
    [No Abstract]   [Full Text] [Related]  

  • 27. Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis.
    Del Olmo E; Molina-Salinas GM; Escarcena R; Alves M; López-Pérez JL; Hernandez-Pando R; Said-Fernández S; Feliciano AS
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5764-8. PubMed ID: 19703769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibiotic policy].
    Cobo Elosua M
    Rev Med Univ Navarra; 1976; 20():135-41. PubMed ID: 1019493
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacterial drug resistance in the community and in hospitals.
    Degener JE; Michel MF; Valkenburg HA; Smit AC; Muller L; Thonus IP
    Neth J Med; 1985; 28(5):182-91. PubMed ID: 4010835
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antibiotic resistance in respiratory tract infections: what can we do?].
    Flückiger U
    Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sensitivity of bacteria to therapeutic drugs (Zurich 1996)].
    Wüst J; Zbinden R; Kayser FH
    Praxis (Bern 1994); 1998 Mar; 87(12):403-12. PubMed ID: 9564237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
    J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic sensitivity of obligate anaerobic bacteria].
    Poliak MS; Miasnikova LG
    Antibiotiki; 1982 May; 27(5):391-6. PubMed ID: 7049072
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention.
    Almeida D; Rodrigues C; Udwadia ZF; Lalvani A; Gothi GD; Mehta P; Mehta A
    Clin Infect Dis; 2003 Jun; 36(12):e152-4. PubMed ID: 12802779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistant tuberculosis in Estonia.
    Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia.
    Kordy FN; Al-Thawadi S; Alrajhi AA
    Int J Tuberc Lung Dis; 2004 Aug; 8(8):1007-11. PubMed ID: 15305485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
    Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
    [No Abstract]   [Full Text] [Related]  

  • 40. Study of primary drug resistance of Mycobacterium tuberculosis from two hospitals in Tenerife, Canary Islands, Spain (1990-1997).
    Lecuona M; Alvarez R; Quintero J; Torres A; Hernández AM; Montesinos I; Sierra A
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):186-7. PubMed ID: 10694101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.